Oramed Pharmaceuticals (ORMP) Q1 2025 Earnings

Mar 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.48
-0.25
-0.01
0.22

Details

Expected EPS
-0.02
Actual EPS
-0.25
Surprise EPS
-0.23
Surprise Percent
-1,150%

Description

⁨Oramed Pharmaceuticals⁩ (⁦ORMP⁩) has reported earnings of ⁦-0.25⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts